A group of pediatricians is urging the Food and Drug Administration to require the sale of infant formula from baby formula manufacturers, citing concerns about its safety and efficacy.
A statement from the American Academy of Pediatrics and the American Pediatric Society said the FDA should require manufacturers to provide infants with a minimum of 30% formula by volume, and to make it available in bottles for infants to use with their parents’ bottles.
According to the statement, this would allow infants to consume formula in bottles that are smaller than their mother’s breast size, and the FDA would be able to track and verify the safety of infant formulas.
The FDA has not required infant formulas to be labeled.
The AAP and the SPCA say the FDA has failed to provide adequate protection against foodborne illness from infant formula.
“The FDA has consistently failed to establish adequate standards and procedures for the safe and effective use of infant and toddler formula, which have led to an increase in cases of foodborne illnesses,” the SPSA and AAP said in the statement.
Since 2000, there have been approximately 4,000 cases of coronavirus in the U.S., according to the CDC.